在临床前心力衰竭中神经道激活. 改造和干预的可能性
G S Francis1, K M McDonald, J N Cohn
1Department of Medicine, University of Minnesota Medical School, Minneapolis.
Circulation
|May 1, 1993
概括
临床前心力衰竭涉及神经内分泌激活和左心室功能障碍. ангиотензин转化酶抑制剂可能会阻断心脏重塑,为预防心力衰竭进展提供潜在的治疗点.
科学领域:
- 心脏病学 心脏病学
- 身体生理学 身体生理学
- 病理学 病理学 病理学
背景情况:
- 充血性心力衰竭 (CHF) 通常遵循一个临床前阶段,无症状的神经内分泌激活和左心室 (LV) 功能障碍.
- 心肌损伤与交感神经系统激活,LV缩和LV体积增加有关.
- 没有受损的心脏组织显示血管激素mRNA和血管激素转化酶活性增加,这表明血管激素II在细胞生长中的作用.
研究的目的:
- 在临床前心力衰竭期间调查神经内分泌激活,LV功能障碍和心脏重塑之间的相互关系.
- 在狗模型中检查急性心肌损伤后心脏的形态和功能变化.
- 评估血管酶转化酶 (ACE) 抑制剂对心脏重塑的作用.
主要方法:
- 使用狗模型诱导急性心肌损伤.
- 在心肌损伤后监测左心室质量,体积和功能的变化.
- 评估了交感神经系统激活和神经内分泌标记物.
- 服用ACE抑制剂,以评估它们对心脏重塑的影响.
主要成果:
- 左心室质量增加是对心肌损伤的初始反应,在1周内观察到.
- 随后是渐进的交感神经系统激活,LV扩张和适度的LV功能障碍.
- 心脏重塑,包括增加 LV 质量和体积,被 ACE 抑制剂显著降低.
结论:
- 急性心肌损伤会引发一连串模仿临床前心力衰竭的事件,包括LV重塑和神经内分泌激活.
- 在心力衰竭的临床前阶段,ACE抑制显示出阻断有害重塑过程的潜力.
- 向宁-血管酶系统可能是一个可行的策略,以防止进展到明显的充血性心力衰竭.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...


